Genus ABS

Genus is a global leader in animal genetics, specializing in the application of biotechnology to improve livestock productivity and animal welfare. The company operates primarily through its ABS (bovine) and PIC (porcine) divisions, providing high-quality semen, embryos, and breeding stock to farmers worldwide. Genus leverages advanced genomic selection and CRISPR gene-editing technologies, most notably in its development of pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS). Additionally, the company offers proprietary sexed semen technology through its IntelliGen platform, enhancing efficiency in the dairy and beef industries. Headquartered in the UK and listed on the London Stock Exchange, Genus plays a critical role in the global food supply chain.